Impact of a reimbursement policy change on treatment with erenumab in migraine - a real-world experience from Germany [0.03%]
德国一项报销政策变更对偏头痛患者使用罗米扎塞坦的影响——德国真实世界经验
Ja Bin Hong,Kristin Sophie Lange,Mira Fitzek et al.
Ja Bin Hong et al.
Background: Monoclonal antibodies (mAbs) targeting the Calcitonin Gene-Related Peptide (CGRP) pathway are safe and effective treatments for migraine prevention. However, the high cost of these novel therapies has led to r...
Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030 [0.03%]
从实现2030年可持续发展目标3健康的角度重新思考头痛这一全球公共卫生案例模型
Paolo Martelletti,Matilde Leonardi,Messoud Ashina et al.
Paolo Martelletti et al.
The 2030 Agenda for Sustainable Development sets out, through 17 Sustainable Development Goals (SDGs), a path for the prosperity of people and the planet. SDG 3 in particular aims to ensure healthy lives and promote well-being for all at al...
BMP7 alleviates trigeminal neuralgia by reducing oligodendrocyte apoptosis and demyelination [0.03%]
BMP7通过减少少突胶质细胞凋亡和脱髓鞘来缓解三叉神经痛
Kai Chen,Xiaojin Wei,Ruixuan Wang et al.
Kai Chen et al.
Background: BMP7 has been shown to have neuroprotective effects and to alleviate demyelination. However, its role in trigeminal neuralgia (TN) has not been well investigated. The current study aims to determine whether BM...
Correction: Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study [0.03%]
纠正：预防性治疗模式和偏头痛治疗满意度：OVERCOME（欧盟）研究结果
Julio Pascual,Tommaso Panni,Grazia Dell&#x;Agnello et al.
Julio Pascual et al.
Published Erratum
The journal of headache and pain. 2023 Oct 20;24(1):142. DOI:10.1186/s10194-023-01679-x 2023
The potent analgesia of intrathecal 2R, 6R-HNK via TRPA1 inhibition in LF-PENS-induced chronic primary pain model [0.03%]
2R, 6R-氢化可托宁通过抑制瞬时受体势锚蛋白1发挥镇痛作用：激光诱导慢性原发性疼痛模型研究
An-Ran Liu,Zhen-Jia Lin,Ming Wei et al.
An-Ran Liu et al.
Background: Chronic primary pain (CPP) is an intractable pain of unknown cause with significant emotional distress and/or dysfunction that is a leading factor of disability globally. The lack of a suitable animal model th...
Characteristic oscillatory brain networks for predicting patients with chronic migraine [0.03%]
慢性偏头痛患者的特征性振荡脑网络
Fu-Jung Hsiao,Wei-Ta Chen,Yu-Te Wu et al.
Fu-Jung Hsiao et al.
To determine specific resting-state network patterns underlying alterations in chronic migraine, we employed oscillatory connectivity and machine learning techniques to distinguish patients with chronic migraine from healthy controls and pa...
Hyperperfusion of bilateral amygdala in patients with chronic migraine: an arterial spin-labeled magnetic resonance imaging study [0.03%]
双侧杏仁核高灌注慢性偏头痛患者的动脉自旋标记磁共振成像研究
Xiaoyan Bai,Wei Wang,Xueyan Zhang et al.
Xiaoyan Bai et al.
Background: Amygdala, an essential element of the limbic system, has served as an important structure in pain modulation. There is still a lack of clarity about altered cerebral perfusion of amygdala in migraine. This stu...
GFAP-NpHR mediated optogenetic inhibition of trigeminal nucleus caudalis attenuates hypersensitive behaviors and thalamic discharge attributed to infraorbital nerve constriction injury [0.03%]
眶下神经压迫损伤大鼠三叉神经脊束核痛行为和丘脑放电的光遗传学干预研究
Elina Kc,Jaisan Islam,Hyong Kyu Kim et al.
Elina Kc et al.
The significance of hyperactive astrocytes in neuropathic pain is crucial. However, the association between medullary astrocytes and trigeminal neuralgia (TN)-related pain processing is unclear. Here, we examined how optogenetic inhibition ...
Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry [0.03%]
德国头痛注册库中专科头痛诊所患者的曲普坦无效性分析：横断面数据
Ruth Ruscheweyh,Gudrun Gossrau,Thomas Dresler et al.
Ruth Ruscheweyh et al.
Background: Triptans are effective for many migraine patients, but some do not experience adequate efficacy and tolerability. The European Headache Federation (EHF) has proposed that patients with lack of efficacy and/or ...
Preventive therapy with galcanezumab for two consecutive cluster bouts in patients with episodic cluster headache: an observational multicenter study [0.03%]
针对丛集性头痛患者的连续丛集发作期预防性使用加尼珠单抗治疗的观察性多中心研究
Yooha Hong,Mi-Kyoung Kang,Heui-Soo Moon et al.
Yooha Hong et al.
Background: Cluster headache is a severe and disabling primary headache disorder. Galcanezumab is a monoclonal antibody against calcitonin gene-related peptide and a preventive therapy for episodic cluster headache. Howev...
Observational Study
The journal of headache and pain. 2023 Oct 10;24(1):136. DOI:10.1186/s10194-023-01661-7 2023